top border
top border
Featured Programs
Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology
Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now
Post-Transplant TMA: Survival with MASP-2 Inhibitors
Vincent T. Ho, MD, of Dana-Farber Cancer Institute, discusses data from a phase II study of narsoplimab in patients with transplant-associated, post-transplant thrombotic microangiopathy (TMA). View Now
Featured Video
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
Daniel Petrylak, MD, and Nicholas Vogelzang, MD, share insight on the emerging role of chemotherapy in metastatic prostate cancer. View now